SQZ Biotechnologies

SQZ

ATLANTA, GA – – (ACCESSWIRE – December 5, 2022) – – Holzer & Holzer, LLC is investigating whether SQZ Biotechnologies Company (“SQZ Bio” or the “Company”) (NYSE: SQZ) complied with federal securities laws.  On December 1, 2022, SQZ Biotechnologies announced that its Chief Executive Officer, Armon Sharei, was stepping down, effective immediately. The Company further announced that its “Board of Directors approved a restructuring plan which includes a workforce reduction of approximately 60 percent.” Following this announcement, the Company’s stock price dropped.

If you purchased SQZ Biotechnologies stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  cholzer@holzerlaw.com  or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/sqz-biotechnologies/ to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Name(Required)
Address
MM slash DD slash YYYY
Shares Purchased(Required)
Number of Shares Acquired
Acquisition Price Per Share
 
MM slash DD slash YYYY
Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.